Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae
- PMID: 36758779
- DOI: 10.1016/j.ijantimicag.2023.106747
Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae
Abstract
Objectives: Hypervirulent carbapenem-resistant Klebsiella pneumoniae (hv-CRKp) has become a great threat to public health. This study reported an hv-CRKp-associated fatal infection and revealed its mechanisms of antimicrobial resistance and within-host evolution.
Methods: A carbapenem-susceptible K. pneumoniae (CSKp) and 11 KPC-producing CRKp strains were isolated from a lung transplant recipient receiving continual antimicrobial therapy for 1.5 years. Pulsed-field gel electrophoresis (PFGE) separated two clusters between CSKp and CRKp.
Results: Further whole genome sequencing analysis found that all 11 CRKp were ST11-KL64 clones, while the CSKp was ST412-KL57. Among these 11 CRKp strains, three and one were resistant to colistin and ceftazidime/avibactam (CAZ/AVI), respectively. Three different mechanisms were found to be responsible for the colistin resistance, including the insertions of two different IS (ISKpn74 and IS903B) into the same position of mgrB and one related to the efflux pump system. CAZ/AVI resistance was associated with blaKPC-2 mutation, and it was also found that increasing blaKPC-2 expression increased the MICs of CAZ/AVI, but not at the resistance level. All these 12 strains had iucABCDiutA virulence cluster and rmpA/rmpA2 genes, with higher siderophore production than a reference classic K. pneumoniae (cKp), which were thought to be hypervirulent K. pneumoniae (hvKp). However, only the CSKp showed higher mucoviscosity according to the mucoviscosity assay. Genomic analysis showed that the rmpA variation (interrupted by ISKpn26) existed in all CRKp strains except the CSKp strain, demonstrating that hypermucoviscous phenotype assays could not accurately identify hvKp.
Conclusion: This study depicted a rapid and diverse within-host evolution of resistance in hv-CRKp of ST11-KL64 clone.
Keywords: Carbapenem-resistant Klebsiella pneumoniae; Hypervirulence; KPC-2; Within-host evolution; mgrB.
Copyright © 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.
Conflict of interest statement
Declarations Funding: This work was supported by the National Natural Science Foundation of China [grant number 82102456]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [grant number CIFMS 2021-I2M-1-048 and CIFMS 2021-I2M-1-030]. Competing Interests: None declared. Ethical Approval: This study was approved by the Ethics Committee of China-Japan Friendship Hospital (2022-KY-054). Written informed consent was waived for the patient, as this research was retrospective and the patient's data were anonymised. Sequence Information: The sequences of strain K28074 were deposited in GenBank database with accession no. CP104551-CP104552 and PRJNA880246 (in progress), while those of strain K30821 were CP107014-CP107019.
Similar articles
-
Investigation of the Rapid Emergence of Colistin Resistance in a Newborn Infected with KPC-2-Producing Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae.J Glob Antimicrob Resist. 2024 Sep;38:265-270. doi: 10.1016/j.jgar.2024.05.021. Epub 2024 Jun 6. J Glob Antimicrob Resist. 2024. PMID: 38849114
-
Analysis of the virulence of a lethal, carbapenem-resistant hypervirulent KPC-33-producing Klebsiella pneumoniae: Emergence of ST11-KL64 hv-CRKP in ICU.Microb Pathog. 2025 Jan;198:107154. doi: 10.1016/j.micpath.2024.107154. Epub 2024 Nov 23. Microb Pathog. 2025. PMID: 39586335
-
Characterization difference of typical KL1, KL2 and ST11-KL64 hypervirulent and carbapenem-resistant Klebsiella pneumoniae.Drug Resist Updat. 2023 Mar;67:100918. doi: 10.1016/j.drup.2023.100918. Epub 2023 Jan 3. Drug Resist Updat. 2023. PMID: 36610180
-
Hypervirulent Klebsiella pneumoniae: Epidemiology outside Asian countries, antibiotic resistance association, methods of detection and clinical management.Enferm Infecc Microbiol Clin (Engl Ed). 2025 Feb;43(2):102-109. doi: 10.1016/j.eimce.2024.12.008. Enferm Infecc Microbiol Clin (Engl Ed). 2025. PMID: 39914938 Review.
-
Carbapenem-resistant Klebsiella pneumoniae in the Balkans: Clonal distribution and associated resistance determinants.Acta Microbiol Immunol Hung. 2024 Feb 21;71(1):10-24. doi: 10.1556/030.2024.02230. Print 2024 Mar 26. Acta Microbiol Immunol Hung. 2024. PMID: 38381174 Review.
Cited by
-
Role of efflux pumps, their inhibitors, and regulators in colistin resistance.Front Microbiol. 2023 Aug 4;14:1207441. doi: 10.3389/fmicb.2023.1207441. eCollection 2023. Front Microbiol. 2023. PMID: 37601369 Free PMC article. Review.
-
Complete genetic characterization of carbapenem-resistant Acinetobacter johnsonii, co-producing NDM-1, OXA-58, and PER-1 in a patient source.Front Cell Infect Microbiol. 2023 Aug 25;13:1227063. doi: 10.3389/fcimb.2023.1227063. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37692162 Free PMC article.
-
Adaptive attenuation of virulence in hypervirulent carbapenem-resistant Klebsiella pneumoniae.mSystems. 2024 Jun 18;9(6):e0136323. doi: 10.1128/msystems.01363-23. Epub 2024 May 16. mSystems. 2024. PMID: 38752758 Free PMC article.
-
Adaptive evolution of carbapenem-resistant hypervirulent Klebsiella pneumoniae in the urinary tract of a single patient.Proc Natl Acad Sci U S A. 2024 Aug 27;121(35):e2400446121. doi: 10.1073/pnas.2400446121. Epub 2024 Aug 16. Proc Natl Acad Sci U S A. 2024. PMID: 39150777 Free PMC article.
-
Global prevalence of mutation in the mgrB gene among clinical isolates of colistin-resistant Klebsiella pneumoniae: a systematic review and meta-analysis.Front Microbiol. 2024 Jun 7;15:1386478. doi: 10.3389/fmicb.2024.1386478. eCollection 2024. Front Microbiol. 2024. PMID: 38912352 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources